http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2349324-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d40960190e37af1e3390c21a67554f98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a2ca8db7045714fae2e7946dbe72d52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_648c15a91ad38a5e43585ef62955658b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9239e9e0cd24d10b4707bcaef14d8392 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 |
| filingDate | 2007-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9168222dc65c7e3ec723be8934d920c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e54e4afb6e52727f11bb97ee6ffadf17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96bc9fd083b403b7a90368456839c1b4 |
| publicationDate | 2009-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2349324-C2 |
| titleOfInvention | Method of complex treatment of soft tissue sarcomas |
| abstract | FIELD: medicine. n SUBSTANCE: invention concerns medicine, particularly oncology, and can be applied in treatment of soft tissue sarcomas. Method involves blood collection from peripheral vein in amount of 100-150 ml before operation of malignant soft tissue tumour removal. Further the blood is centrifuged, plasma is collected to two bottles in equal amount. 600 mg of cyclopohsphane is added to the first bottle, 40 mg of methotrexate is added to the second bottle, and both bottles with plasma and chemicals are incubated for 30 minutes at 37°C. After tumour removal, removed tumour bed and surrounding tissues are infiltrated with contents of first bottle and then of second bottle. Remaining structural blood elements are mixed with 100 ml of saline solution and reinfused till the end of operation. n EFFECT: prolonged recurrence-free period, prevented toxic side effects; infiltration of tissues surrounding tumour with maximum quantity of anti-tumour drugs due to creation of chemical drug depot in the tissues; possible surgical tumour removal without extremity amputation and disabiling of patients. n 1 ex |
| priorityDate | 2007-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.